ChemicalBook >> CAS DataBase List >>Niaprazine

Niaprazine

CAS No.
27367-90-4
Chemical Name:
Niaprazine
Synonyms
Nopron;1709 CERM;Niaprazine;Niaprazine, 10 mM in DMSO;N-(4-(4-(4-FLUOROPHENYL)PIPERAZIN-1-YL)BUTAN-2-YL)NICOTINAMIDE;N-[3-[4-(p-Fluorophenyl)-1-piperazinyl]-1-methylpropyl]nicotinamide;N-[3-[4-(4-Fluorophenyl)-1-piperazinyl]-1-methylpropyl]nicotinamide;N-[3-[4-(4-Fluorophenyl)-1-piperazinyl]-1-methylpropyl]-3-pyridinecarboxamide;3-Pyridinecarboxamide, N-[3-[4-(4-fluorophenyl)-1-piperazinyl]-1-methylpropyl]-;5-HIAA,disorders,sleep,autistic,Histamine Receptor,inhibit,5-HT2,sedative,Inhibitor,Niaprazine,H1-receptor
CBNumber:
CB2875198
Molecular Formula:
C20H25FN4O
Molecular Weight:
356.4371032
MDL Number:
MFCD00867991
MOL File:
27367-90-4.mol
MSDS File:
SDS
Last updated:2026-07-14 16:49:18

Niaprazine Properties

Melting point 131℃
Density 1.165
storage temp. Store at -20°C
solubility DMSO: 100 mg/mL (280.55 mM)
form Solid
color White to off-white
FDA UNII R2H3YN6E3L
ATC code N05CM16

SAFETY

Risk and Safety Statements

Symbol(GHS)  Health Hazard (GHS08)
GHS08
Signal word  Warning
Hazard statements  H351
Precautionary statements  P501-P202-P201-P280-P308+P313-P405
Toxicity LD50 in mice (mg/kg): 890 orally, 145 i.v. (Mauvernay)

Niaprazine price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Biosynth FN104313 Niaprazine 27367-90-4 25mg $278.75 2026-06-04 Buy
Biosynth FN104313 Niaprazine 27367-90-4 50mg $446 2026-06-04 Buy
Biosynth FN104313 Niaprazine 27367-90-4 100mg $668 2026-06-04 Buy
Biosynth FN104313 Niaprazine 27367-90-4 250mg $1112.5 2026-06-04 Buy
Biosynth FN104313 Niaprazine 27367-90-4 500mg $1785 2026-06-04 Buy
Product number Packaging Price Buy
FN104313 25mg $278.75 Buy
FN104313 50mg $446 Buy
FN104313 100mg $668 Buy
FN104313 250mg $1112.5 Buy
FN104313 500mg $1785 Buy

Niaprazine Chemical Properties, Uses, Production

Originator

Nopron,Carrion,France,1976

Uses

Niaprazine comprises norepinephrine reuptake inhibitors (NRIs), non-myorelaxing hypnotic agents and 5-HT2A inverse agonists or antagonists for treating sleep apnea.

Definition

ChEBI: Niaprazine is a member of piperazines.

Manufacturing Process

1st Stage: 10 ml of concentrated (10 N) hydrochloric acid and 240 ml of acetone were added to a solution of 217.5 g (1 mol) of 1-(4- fluorophenyl)piperazine dihydrochloride in 400 ml of 96% ethanol. 50 g of powdered trioxymethylene were then added and the mixture was then slowly heated to reflux, which was maintained for 1 hour. A further 60 g of trioxymethylene were then added and heating to reflux was continued for a further 6 hours.
The mixture was then cooled, the precipitate formed was filtered off, washed with acetone and recrystallized from 96% ethanol.
The base was liberated from its salt by taking up the product in an aqueous solution of sodium bicarbonate. The precipitate of the base thus obtained was recrystallized from petroleum ether to give 160 g of the desired product; melting point 46°C; yield 64%.
2nd Stage: 45.5 g (0.65 mol) of hydroxylamine hydrochloride were added to a solution of 128 g (0.5 mol) of the amino-ketone obtained in the preceding stage in 100 ml of ethanol and 40 ml of water. The mixture was allowed to react for 15 minutes at room temperature and was then heated to reflux for hour. A part of the solvent was then distilled off and the product was then allowed to crystallize on cooling. After recrystallization from 96% ethanol, 117 g of the desired product were obtained; melting point 170°C; yield 77%.
3rd Stage: 93 g (0.35 mol) of the oxime obtained in the preceding stage, in the form of the base, were added in portions to a suspension of 17 g (0.45 mol) of lithium aluminum hydride in 400 ml of anhydrous ether. The mixture was then heated to reflux for 15 hours.
10 ml of ethyl acetate and then 50 ml of dilute caustic soda were added slowly with the usual precautions to the mixture. The organic phase was separated, dried over anhydrous Na2SO4, the solvent was distilled off and the residue obtained was distilled under reduced pressure to give 51 g of a thick oil; boiling point (2 mm Hg), 142°C to 143°C; yield 58%.
4th Stage: 10 ml of triethylamine were added in a solution of 25.2 g (0.1 mol) of the amine obtained in the preceding stage in 100 ml of anhydrous chloroform and the mixture was cooled to 2°C to 3°C. While maintaining this temperature, 17 g (0.12 mol) of nicotinic acid chloride were added with vigorous agitation.
After evaporation of the solvent, the residue was washed with water, the product taking the form of a mass. After recrystallization from ethyl acetate, a constant melting point of 131°C was obtained.

Therapeutic Function

Antihistaminic

Global Suppliers ( 39)
Supplier Tel Email Country ProdList Advantage
Finetech Industry Limited 027-87465837 19945049750 sales@finetechnology-ind.com China 9331 58
Shanghai Join Biological Pharmaceutical Co., Ltd. 13818361018 shzuolin@163.com China 49 50
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
Aikon International Limited 025-58859352 13913916777 dt3@aikonchem.com China 15490 58
TargetMol Chemicals Inc. +1-781-999-5354; +1-00000000000 marketing@targetmol.com United States 32431 58
Finetech Industry Limited +86-27-8746-5837 +86-18627785180 info@finetechnology-ind.com China 9533 58
CONIER CHEM AND PHARMA LIMITED sales@conier.com China 49906 58
SHANDONG OCTAGON CHEMICALS LIMITED 0535-15589503653 15589503653 2959135512@qq.com China 193 58
Beijing Jin Ming Biotechnology Co., Ltd. 010-60605840 psaitong@jm-bio.com China 27626 58
Anqing Rong Chuang Biological Technology Co., Ltd. 15001988657 Sales_zhao@bookchemicals.com China 981 58

View Latest Price from Niaprazine manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Niaprazine pictures 2026-07-13 Niaprazine
27367-90-4
$30.00-96.00 99.56% 10g TargetMol Chemicals Inc.
  • Niaprazine pictures
  • Niaprazine
    27367-90-4
  • $30.00-96.00
  • 99.56%
  • TargetMol Chemicals Inc.

Niaprazine Spectrum

Niaprazine 1709 CERM N-[3-[4-(4-Fluorophenyl)-1-piperazinyl]-1-methylpropyl]nicotinamide N-[3-[4-(p-Fluorophenyl)-1-piperazinyl]-1-methylpropyl]nicotinamide N-[3-[4-(4-Fluorophenyl)-1-piperazinyl]-1-methylpropyl]-3-pyridinecarboxamide Nopron N-(4-(4-(4-FLUOROPHENYL)PIPERAZIN-1-YL)BUTAN-2-YL)NICOTINAMIDE 3-Pyridinecarboxamide, N-[3-[4-(4-fluorophenyl)-1-piperazinyl]-1-methylpropyl]- 5-HIAA,disorders,sleep,autistic,Histamine Receptor,inhibit,5-HT2,sedative,Inhibitor,Niaprazine,H1-receptor Niaprazine, 10 mM in DMSO 27367-90-4 C20H25FN4O APIs